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Abstract
The novel Coronavirus associated with respiratory illness has become a new threat to human health as it is spreading
very rapidly among the human population. Scientists and healthcare specialists throughout the world are still looking
for a breakthrough technology to help combat the Covid-19 outbreak, despite the recent worldwide urgency. The use of
Machine Learning (ML) and Artiﬁcial Intelligence (AI) in earlier epidemics has encouraged researchers by providing a
fresh approach to combating the latest Coronavirus pandemic. This paper aims to comprehensively review the role of AI
and ML for analysis of gene expressed data of COVID-19.
Keywords: Coronavirus, Repurposing, COVID-19, Machine learning, Artiﬁcial intelligence

1. Introduction

T

he coronavirus (COVID-19) emerged in
China is a pandemic and has become a global
threat to human health by rapidly spreading its
infection from human to human, transmitting to
multiple countries and thus the WHO (World Health
Organization) has declared it as a global health
emergency [1]. The corona infection was ﬁrst reported
in Wuhan, China, and the patient was hospitalized on
12 December 2019 and the disease outbreak was
associated with the seafood market in Wuhan, China
[2]. This emerging coronavirus pathogen was characterized as a new member of beta coronaviruses which
is very closely associated with bat coronaviruses
causing SARS. This virus mainly affects birds and

mammals by causing mild illnesses like the common
cold and respiratory tract infections but in the later
stages, it might also cause MERS, SARS, and COVID19 could lead to fatal illness [3]. Six coronavirus strains
are said to cause the disease among which four strains
(229E, OC43, NL63, and HKU1) are prevalent and
cause common cold in individuals [4]. The other two
strains (SARS-CoV and MERS-CoV) have a zoonotic
origin and cause lethal illness. The SARS-CoV strain
was responsible to cause an outbreak of severe acute
respiratory syndrome in China in the years 2002 and
2003 [5]. The MERS-CoV strain was responsible to
cause a respiratory syndrome in the Middle East in the
year 2012 and was capable of transmitting the infection
in both humans to humans and animals to humans. It
is detected that the present CoV-19 belongs to the
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beta-coronavirus genus but it is distinct from SARSCoV and MERS-CoV [6].
The COVID-19 virus incubation period is 1e14
days and is highly diffusible that it transmits and
spreads from direct contact, droplets from the
infected people, through infected objects and also
from asymptomatic infected people [7]. Infected
individuals usually show no symptoms or might
show mild to moderate respiratory symptoms. The
mortality rate of COVID-19 in young generations is
about 0.2% while the older individuals age 80 or
more than that have the highest rate of mortality [8].
A lot of measures and strategies have been
implemented worldwide to control and prevent this
infection as there is no antiviral drug or vaccines
available. The drugs, vaccines and immunotherapeutics available for different viral infections like
Ebola, Nipah and Zika have been tested against
COVID-19 to check their efﬁcacy and potency to
tackle the emerging pandemic [2]. There is a critical
response in identifying a particular drug to treat
against COVID-19 to its spike glycoprotein that has
a key role in virus-cell receptor infection; hence
treating such severe inﬂuenza is still a challenge [9].
The best way to lower the number of overall cases of
the pandemic is to include non-pharmaceutical interventions such as physical/social distancing; this
approach of controlling the further spread of infection is very helpful as it reduces the pressure on
healthcare workers [10].
Corona Virus belongs to the Corona viridae family
and subfamily of Corona virinae which infects the
host in a wide range that causes SARS in the host.
COVID-19 is enveloped with helical symmetry of
nucleocapsid and a þssRNA (positive-sense, singlestranded RNA) [11]. COVID-19 is known to be an
RNA virus as its RNA genome is one of the largest
among the viruses and consists of 29,727 nucleotides
[12]. The virus diameter ranges from 70 to 120 nm.
The genomic sequence analysis of CoV-19 has
shown that it belongs to the Beta-coronavirus genus
including the MERS and SARS. The coronavirus
genome consists of 14 ORFs (open reading frames)
that can code for 27 proteins [13]. The 15 nonstructural proteins involved in the virus replication
are encoded from the ORF1 and ORF2 at the
50 -terminal region of the virus genome [14]. The
structural proteins such as nucleocapsid (N), membrane protein (M), envelope protein (E) and spike
protein (S) and eight accessory proteins are encoded
from the 30 -terminal region of their genome [15].
The virus is surrounded by spike-shaped proteins
(glycoproteins) which is the main receptor responsible to cause the host cell infection. It was demonstrated that S of CoV-19 interacts with ACE-2

(Angiotensin Converting Enzyme 2) to enter the
host's cell particularly the alveolar epithelial cells.
The comparative genomic studies have shown 380
amino acid substitution between SARS and SARSCoV, with 27 gene mutations found on the genes
responsible for code S [16]. Upon the recognition of
the host cell, S protein of the virus cleaves itself and
forms two subunits namely S1 and S2 which are
non-covalently bound to one another. During the
viral entry, the S1 subunit is responsible for the hostreceptor binding interaction and the S2 subunit
consists of membrane fusion machinery that helps in
the fusion of viral and host membranes allowing the
release of the viral genome into the host cells [17].
The primary function of N protein is to protect the
viral genome from extracellular agents by forming
of viral capsid called nucleocapsids which are ﬂexible, long helical ribonucleoprotein (RNP). The
fragments of N protein with its dimerization domain
will bind to the RNA-binding site in the region between 248 and 280 residues within the viral RNA
genome [18]. The nucleocapsid plays a major role in
protecting the genome by ensuring reliable replication and transmission of it. The main core
component is the M protein where its 16 amino acid
domain binds with the N protein through ionic interactions leading in the encapsidation of the
budding virus. Studies suggest that the complex of
M protein and the nucleocapsid is stabilized due to
the interaction that associates M with N protein [19].
The formation of the viral envelope is associated
with the E protein as it binds to the BRD2 and BRD4
(bromodomain-containing proteins). BRD2 helps in
regulating the gene transcription by binding with
acetylated histones that share a similar sequence of
15 residues over E protein. E is very beneﬁcial to the
virus as it disrupts its interaction with BRD2 by
mimicking its histones, and thus induces the change
in the expression of the host's protein [20].

2. Treatment
COVID-19 is now global pathogen with no antiviral drugs, interventions, or vaccines available.
Well to design targeted therapeutics against
COVID-19, there is a need to understand the virus
molecular mechanism involved in its replication
and pathogenesis [21]. The scientists have discovered several methods that could lead to the discovery of a potential antiviral drug for the treatment
of present COVID-19 human pathogen. The ﬁrst
method is to select the antiviral drugs used to treat
other viral infections [22]. The drugs selected under
this method include interferon I and interferon II
which are good at their pharmacodynamic and
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pharmacokinetic activities. Whereas there is no
speciﬁc evidence of how these drugs act on the
coronavirus [23]. In the second method, screening of
the existing compounds from the database or library
has been carried out. After screening, the selected
compounds are further evaluated for their antiviral
activities. This method is also termed as drug
repurposing as the compounds selected from the
screening process are used to treat a particular
disease [24]. The third method is to redevelop a new
medication to treat the coronavirus based on their
genomic sequence.

3. Prevention of infection
The current strategy to prevent and limit the
infection from spreading is to follow certain measures. The measures to control the infection include
social distancing, isolation of patients, appropriate
steps adopted in the diagnosis (precautions taken
during specimen collection), and giving proper
clinical care to an infected patient [25]. The most
common and important measure undertaken to
control the spread of infection is to frequent hand
wash, usage of hand sanitizers, and face masks. The
transmission of pathogens must be prevented in the
healthcare workers in the hospitals caring for the
infected individuals and the usage PPE kits that
include N95 or FFP3 face masks, gloves, gowns, and
eye protection has made compulsory [26].
To combat this global novel pandemic, WHO, scientists, and clinicians in the medical industry are
looking for new technology to screen infected patients
at various stages, ﬁnd the best clinical trials, control the
virus's spread, develop a vaccine to cure infected patients, and track infected patients' contacts [27]. Machine Learning and Artiﬁcial Intelligence, according to
recent studies, are promising technologies used by
various healthcare providers because they provide
better scale-up, faster processing power, and even
outperform humans in speciﬁc healthcare jobs [28]. As
a result, healthcare companies and physicians around
the world used a variety of machine learning and
artiﬁcial intelligence (AI) technologies to combat the
COVID-19 epidemic and address the issues that arose
during the outbreak. This work seeks to provide an
artiﬁcial intelligence-based system for genome
sequence analysis of COVID-19, which is inspired by
the previous debate and the advancement of artiﬁcial
intelligence in genome sequence analysis.

4. Genomics of COVID-19
The virus's initial genome sequence was made
available on January 10, 2020, 9 days after the ﬁrst
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probable COVID-19 patient was found. Thousands
more samples have been sequenced worldwide since
then [29]. One of the most promising ﬁelds of research
for COVID-19 is genomics, which is concerned with
an organism's genetic content. Genome sequence
analysis uses information from an organism's
genome to help clinical specialists make more
tailored therapy or diagnostic decisions. Experts want
to better inform public health, make smarter judgments, and identify effective treatments by unlocking
the virus's genetic code and the most severely
impacted hosts (patients). The nucleic acids of an
organism are made up of four nucleotide bases
(Adenine-A, Guanine-G, Cytosine-C, and ThymineT) stored as an encoded sequence in the genome. The
unique COVID-19 genome sequence is an enclosed
single-stranded positive-sense RNA (Ribonucleic
acid) from the Coronavirus family, which is around
30 kB long and divided into three groups, two of
which cause infections in mammals, such as bat
SARSCoV-like diseases (MERS-CoV) [30].
The identiﬁcation of nucleotides in a genome
sequence is known as genome sequence analysis.
Until now, the COVID-19 or SARS-CoV-2 genome
had been sequenced by multiple organisations
across the world, providing information on the
virus's various strains [31]. The identiﬁcation of
genome features aids biomedical specialists in
making predictions regarding these features' impact
on disease implications in the population. Despite
the fact that it is usually a time-consuming and
resource-intensive technique that relies heavily on
ﬁeld experience. Various strains of COVID-19's ﬁrst
genome sequencing failed to produce timely
actionable conclusions, and many aspects of disease
behaviour remain unexplained [32].

5. Machine learning employed for genome
sequence analysis of COVID-19
Artiﬁcial intelligence and related technologies, such
as data analysis [33], machine learning [34], and deep
learning [35], can help speed up the process of identifying actionable insights while also improving global
response. Computational approaches that enable the
study of massive, complex, and high-dimensional
genomic data sets are in high demand [36]. Artiﬁcial
intelligence can help to stimulate new discoveries in
large data sets without requiring explicit rules or interests at various stages of the genomic data pipeline
as shown in Fig. 1. The analysis and perception stage
has seen the most developed work in artiﬁcial intelligence using genomic data sets [37]. Artiﬁcial
intelligence has made tremendous progress in
clinical genome analysis, including phenotyping in
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Fig. 1. Figure depicting how artiﬁcial intelligence and machine learning can help in preventing the COVID-19 infection.

uncommon syndromes, cancer, and its variations
research and explanation [38]. Although, in the ﬁeld of
genomics, most artiﬁcial intelligence-based work is
still in the research phase. Machine and deep learning
approaches are in high demand for functional genomics analysis. These techniques have been used to
track most elements of genome analysis, including
genome sequencing, phenotyping, and variation
detection, as well as downstream analysis [39]. Improvements in computation, artiﬁcial intelligence, and
the growth of biological data sets now allow for advancements in existing service domains. Simultaneously, advances in open access research and opensource tools enable the application and success of
artiﬁcial intelligence in a variety of genetic investigations [40]. Furthermore, good software distributors include machine learning algorithms into their
genomic analysis tools and services, using publicly
available resources.
Researchers can use artiﬁcial intelligence and data
analytics approaches to better comprehend factors,
behaviors, and data trends in a variety of scenarios,

issues, and diseases. Statistical, data mining, and
machine learning approaches were used in early
research and studies for many types of investigations such as predicting and risk assessments
[41] of various diseases.

6. Machine learning algorithms
This section gives a quick rundown of the machine learning algorithms that can be used to
analyze of gene expression data for COVID-19. The
use of machine learning to combat COVID-19 is
critical in the current circumstances.
6.1. K nearest neighbours (KNN)
The classiﬁcation in this case is based on the data
points' location. The number of neighbours is used
to group similar objects together. Non-parametric
categorization is used. There are no assumptions
made regarding the data. It's also known as a lazy
learner algorithm because the learning process is
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delayed and the action is only performed after the
data is classiﬁed [42]. The minimum number of
neighbours necessary is set to k by the user. In
general, the predictions are more reliable when the
value of k is larger. To improve classiﬁcation accuracy, weights are attached to the neighbours [43].
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nodes in one layer are connected to the nodes in the
preceding and subsequent layers. The inputs are
processed by an activation function. One layer's
output becomes the input for the following layer.
The location of the user was determined using ANN
and IoT. Although the data was restricted, the accuracy was great [48].

6.2. Support vector machine (SVM)
The data is divided into separate groups using a
hyperplane. To locate the smallest gap between data
points, SVM calculates the maximum marginal
distance. Hyperplanes serve as borders, dividing
data points into categories. When there are just two
attributes, a single line exists. When the input size is
increased to three, a 2D plane is created [44]. It becomes increasingly harder to see the hyperplane as
the number of characteristics grows.
6.3. Logistic regression
It uses a sigmoid curve as a cost function to predict a categorical variable (dependent variable)
based on one or more independent factors. The
Sigmoid function (Logistic function) is an S-shaped
curve that divides data into classes. Binomial,
multinomial, and ordinal classiﬁcations can all
beneﬁt from logistic regression [45].
6.4. Decision trees
The outcome is predicted by the leaf nodes, decisions are made by the branches, and characteristics are internal nodes in a decision tree. Decision
trees distribute instances by assembling them down
the tree from the root to the leaf nodes, resulting in
the instance's classiﬁcation [46].
6.5. Random forests
When the data is big, classiﬁcation using a decision tree might lead to overﬁtting. Random forests
can help us overcome these restrictions. To boost
accuracy, different decision trees are categorized
and then combined together. “Bagging” is the term
for this process. The spatialetemporal distribution
of COVID-19 daily cases around the world was
estimated using a random forest machine learning
approach [47].

7. Discussion and conclusion
Since the outbreak of the novel SARS-CoV-2 virus,
scientists and medical industries all over the world
have been urging people to ﬁght the pandemic by
looking for alternative methods of rapid screening and
prediction, contact tracing, forecasting, and vaccine or
drug development that is more accurate and reliable
[49]. Machine Learning and Artiﬁcial Intelligence are
two promising technologies that are being used by a
variety of healthcare providers [50]. This study examines recent studies that use advanced technology to
assist researchers in a variety of ways, addressing the
difﬁculties and obstacles that arise when utilizing such
algorithms to assist medical experts in real-world
problems. The application of modern technology with
AI and ML increases screening, prediction, contact
tracing, forecasting, and drug/vaccine development
with extraordinary dependability, according to this
review. Deep learning algorithms were used in the
majority of the papers and were determined to have
greater potential, robustness, and advancement than
other learning algorithms. However, given the current
urgency, an improved model with high-end performance accuracy in screening and predicting SARSCoV-2 with a different type of linked disease by
assessing clinical, mammographic, and demographic
data of suspects and infected patients is required.
Finally, it is clear that AI and machine learning may
dramatically improve Covid-19 pandemic therapy,
medication, screening and prediction, forecasting,
contact tracking, and drug/vaccine research while
reducing human engagement in medical practice. The
majority of the models, however, have not been
deployed enough to demonstrate their real-world
functionality, but they are still capable of combating
the epidemic.
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